Patent · US Active

Inhibitors of hemeprotein-catalyzed lipid peroxidation

US10675285B2 · kind B2 · utility

0Cited by
22References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 15, 2015
Grant dateJun 9, 2020
Priority date
Expiry dateSep 15, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D498/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods and compounds for the treatment or prevention of oxidative damage in a mammalian subject. The treatment and/or prevention may be on inhibiting heme-induced lipid peroxidation. Also discloses are methods and compounds for treating or preventing isoprostane-mediated tissue damage.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.